Matches in Wikidata for { <http://www.wikidata.org/entity/Q48628008> ?p ?o ?g. }
- Q48628008 description "2011 nî lūn-bûn" @default.
- Q48628008 description "2011年の論文" @default.
- Q48628008 description "2011年学术文章" @default.
- Q48628008 description "2011年学术文章" @default.
- Q48628008 description "2011年学术文章" @default.
- Q48628008 description "2011年学术文章" @default.
- Q48628008 description "2011年学术文章" @default.
- Q48628008 description "2011年学术文章" @default.
- Q48628008 description "2011年學術文章" @default.
- Q48628008 description "2011年學術文章" @default.
- Q48628008 description "2011年學術文章" @default.
- Q48628008 description "2011年學術文章" @default.
- Q48628008 description "2011年學術文章" @default.
- Q48628008 description "2011년 논문" @default.
- Q48628008 description "article científic" @default.
- Q48628008 description "article scientific" @default.
- Q48628008 description "article scientifique" @default.
- Q48628008 description "articol științific" @default.
- Q48628008 description "articolo scientifico" @default.
- Q48628008 description "artigo científico" @default.
- Q48628008 description "artigo científico" @default.
- Q48628008 description "artigo científico" @default.
- Q48628008 description "artikel ilmiah" @default.
- Q48628008 description "artikull shkencor" @default.
- Q48628008 description "artikulong pang-agham" @default.
- Q48628008 description "artykuł naukowy" @default.
- Q48628008 description "artículo científico publicado en 2011" @default.
- Q48628008 description "artículu científicu" @default.
- Q48628008 description "bilimsel makale" @default.
- Q48628008 description "bài báo khoa học" @default.
- Q48628008 description "naučni članak" @default.
- Q48628008 description "scienca artikolo" @default.
- Q48628008 description "scientific article published on 18 July 2011" @default.
- Q48628008 description "scientific article published on 18 July 2011" @default.
- Q48628008 description "scientific article published on 18 July 2011" @default.
- Q48628008 description "teaduslik artikkel" @default.
- Q48628008 description "tieteellinen artikkeli" @default.
- Q48628008 description "tudományos cikk" @default.
- Q48628008 description "vedecký článok" @default.
- Q48628008 description "vetenskaplig artikel" @default.
- Q48628008 description "videnskabelig artikel" @default.
- Q48628008 description "vitenskapelig artikkel" @default.
- Q48628008 description "vitskapeleg artikkel" @default.
- Q48628008 description "vědecký článek" @default.
- Q48628008 description "wetenschappelijk artikel" @default.
- Q48628008 description "wissenschaftlicher Artikel" @default.
- Q48628008 description "επιστημονικό άρθρο" @default.
- Q48628008 description "мақолаи илмӣ" @default.
- Q48628008 description "наукова стаття, опублікована в липні 2011" @default.
- Q48628008 description "научна статия" @default.
- Q48628008 description "научная статья" @default.
- Q48628008 description "научни чланак" @default.
- Q48628008 description "научни чланак" @default.
- Q48628008 description "מאמר מדעי" @default.
- Q48628008 description "مقالة علمية نشرت في 18 يوليو 2011" @default.
- Q48628008 description "১৮ জুলাই ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q48628008 description "บทความทางวิทยาศาสตร์" @default.
- Q48628008 description "სამეცნიერო სტატია" @default.
- Q48628008 name "Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer." @default.
- Q48628008 name "Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer." @default.
- Q48628008 type Item @default.
- Q48628008 label "Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer." @default.
- Q48628008 label "Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer." @default.
- Q48628008 prefLabel "Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer." @default.
- Q48628008 prefLabel "Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer." @default.
- Q48628008 P1433 Q48628008-52384297-C333-4586-921A-4BFB2FE1114D @default.
- Q48628008 P1476 Q48628008-3841922B-6BE5-4567-99DA-69ACD53DD7F6 @default.
- Q48628008 P2093 Q48628008-12652DA1-E272-4FA9-B173-5A26FC2319A6 @default.
- Q48628008 P2093 Q48628008-468FAEF0-6913-4D32-B841-6F6CD19948A5 @default.
- Q48628008 P2093 Q48628008-5002A3EF-8FE9-4D28-862B-91D165A7B6B6 @default.
- Q48628008 P2093 Q48628008-92F323A5-76C2-4C90-980B-600C1D07A42C @default.
- Q48628008 P2093 Q48628008-9447C3B2-000A-4125-83EC-4D4CC0555B61 @default.
- Q48628008 P2093 Q48628008-980A810C-7243-4252-81BE-7B081354DCED @default.
- Q48628008 P2093 Q48628008-9A19DF69-BD89-4C5A-ABEB-B631B4EA9807 @default.
- Q48628008 P2093 Q48628008-C385C158-7A2F-4E9A-AA5F-E142BDFACDA4 @default.
- Q48628008 P2093 Q48628008-C79DA4B3-9C91-4367-9506-37CB505646B7 @default.
- Q48628008 P2093 Q48628008-CEB3AC22-FFA0-4AD5-81F7-AFDB7A722BCB @default.
- Q48628008 P2093 Q48628008-D2A8575C-A638-416E-A37C-54E6F6E9C563 @default.
- Q48628008 P2093 Q48628008-D9A6039E-82B7-4BF2-B3E9-EAFC615DEAF4 @default.
- Q48628008 P2093 Q48628008-E7B3BE47-AED8-4711-B3AF-BCE275DDCF0E @default.
- Q48628008 P2093 Q48628008-FD641259-0BD3-46B6-B7F6-2EA3B059F992 @default.
- Q48628008 P304 Q48628008-470848C2-F24C-48FB-9CCA-689E8A15EAF7 @default.
- Q48628008 P31 Q48628008-F90F4652-42B7-4CFE-9FA7-636A9D98A0B5 @default.
- Q48628008 P356 Q48628008-C1ED2963-8EDC-47AF-9091-7642BDAB15ED @default.
- Q48628008 P407 Q48628008-038A3B47-CD9B-406C-907D-138C90FC1F11 @default.
- Q48628008 P433 Q48628008-A26F8E33-3648-47F6-B9C1-AA1178C252D3 @default.
- Q48628008 P478 Q48628008-BB8DA285-8F93-40E3-962C-9E9C5AEDB626 @default.
- Q48628008 P50 Q48628008-2E234A99-BDF8-4B14-ADA2-22ABE92055A4 @default.
- Q48628008 P50 Q48628008-F12EC3AC-0958-452D-ADCD-A77D1E3EAAD9 @default.
- Q48628008 P50 Q48628008-F37B2AF3-EF98-449F-9BB2-C27567E7D16F @default.
- Q48628008 P577 Q48628008-8A86C161-383E-4304-BA89-A59D05DFE83A @default.
- Q48628008 P698 Q48628008-D80DF796-CB36-47F2-AA1E-520311A076BF @default.
- Q48628008 P8608 Q48628008-8B661E59-3C47-4F4C-BD1C-DC663C38D9D7 @default.
- Q48628008 P921 Q48628008-4F849E4F-90C9-42A8-893E-F9A376485B0B @default.
- Q48628008 P921 Q48628008-8A01CE7F-EB26-4DF0-BCDD-932DC74F74B9 @default.
- Q48628008 P356 JCO.2010.32.7254 @default.
- Q48628008 P698 21768453 @default.
- Q48628008 P1433 Q400292 @default.
- Q48628008 P1476 "Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer." @default.
- Q48628008 P2093 "Alejandro Tres" @default.